Tesla’s Regulatory Win Fails to Offset Robotaxi Delays as Stock Struggles
Tesla's minor regulatory victory—the NHTSA closing its investigation into 2023 Model Y steering wheel bolts without a recall—did little to buoy the stock. Shares edged up 0.4% before retreating, reflecting broader investor skepticism.
Q1 earnings delivered mixed signals: a $0.41 EPS beat against $0.39 estimates, but revenue missed at $22.39B versus $22.96B expected. The real drag? Slowed progress on Robotaxi and Optimus projects, coupled with a $25B capex plan threatening free cash flow.
Year-to-date, TSLA is down 16%, opening Tuesday at $378.67. The market's verdict is clear: execution risks outweigh regulatory reprieves.
Log in to Reply
Log in to comment your thoughtsComments
Related Articles
|Square
Get the BTCC app to start your crypto journey
Get started today Scan to join our 100M+ users